Background/Aims: The ‘McClintock mechanism’ of chromosome breakage and centromere misdivision, in which a deleted chromosome with its concomitant excised marker or ring chromosome is formed, has been described in approximately one dozen reports. We report a case of a girl with short stature, developmental delay, and dysmorphic features. Methods: Analysis was performed on the proband and father using cytogenetic chromosome analysis and the Affymetrix 6.0 SNP microarray. Fluorescence in situ hybridization (FISH) using a chromosome 8 alpha-satellite probe and immunofluorescence with antibodies to CENP-C were used to examine the centromere positions in these chromosomes. Results: An abnormal chromosome 8 with a cytogenetically visible deletion was further defined by SNP array as a 10.6-Mb deletion from 8q11.1→q12.1. FISH with a chromosome 8 alpha-satellite probe demonstrated that the deletion removed a significant portion of the pericentromeric alpha-satellite repeat sequences and proximal q arm. The deleted chromosome 8 appeared to have a constriction at 8p22, suggesting the formation of a neocentromere, even though alpha-satellite sequences still appeared at the normal location. Chromosome analysis of the phenotypically normal father revealed the same deleted chromosome 8, as well as an apparently balancing mosaic marker chromosome 8. FISH studies revealed that the majority of the chromosome 8 alpha-satellite DNA resided in the marker chromosome. Immunofluorescence studies with antibodies to CENP-C, a kinetochore protein, proved the presence of a neocentromere at 8p22. The excision of the marker from the deleted chromosome 8 likely necessitated the formation of a new kinetochore at the 8p22 neocentromere to stabilize the chromosome during mitosis. Conclusion: This case clearly illustrates the utilization of classic cytogenetics, FISH, and array technologies to better characterize chromosomal abnormalities and provide information on recurrence risks. It also represents a rare case where a neocentromere can form even in the presence of existing alpha-satellite DNA.

1.
Amor DJ, Bentley K, Ryan J, Perry J, Wong L, et al: Human centromere repositioning ‘in progress’. Proc Natl Acad Sci USA 101:6542–6547 (2004).
2.
Andersen LB, Tommerup N, Koch J: Formation of a minichromosome by excision of the proximal region of 17q in a patient with von Recklinghausen neurofibromatosis. Cytogenet Cell Genet 53:206–210 (1990).
3.
Asamoah A, Nwankwo M, Kumar SP, Ezhuthachan SG, Van Dyke DL: Proximal chromosome 8q deletion in a boy with femoral bifurcation and other multiple congenital anomalies. Am J Med Genet A 127A:65–68 (2004).
4.
Baldwin EL, May LF, Justice AN, Martin CL, Ledbetter DH: Mechanisms and consequences of small supernumerary marker chromosomes: from Barbara McClintock to modern genetic-counseling issues. Am J Hum Genet 82:398–410 (2008).
5.
Friedman JM, Harrod MJ, Howard-Peebles PN: Complementary duplication and deletion of 17(pcen–p11.2): a family with a supernumerary chromosome comprised of an interstitially deleted segment. Am J Med Genet 44:37–40 (1992).
6.
Fryns JP, Kleczkowska A, Limbos C, Vandecasseye W, Van den Berghe H: Centric fission of chromosome 7 with 47,XX,del(7)(pter–cen::q21–qter)+cen fr karyotype in a mother and proximal 7q deletion in two malformed newborns. Ann Genet 28:248–250 (1985).
7.
ISCN 2009: An International System for Human Cytogenetic Nomenclature, Shaffer LG, Slovak ML, Campbell LJ (eds). Karger, Basel 2009.
8.
Kazukawa S, Endo M, Fujii T, Hori A, Yamada K, et al: Interstitial deletion of the long arm of chromosome 8 without Langer-Giedion syndrome. Jpn J Psychiatry Neurol 40:221–226 (1986).
9.
Kosztolanyi G: Does ‘ring syndrome’ exist? An analysis of 207 case reports on patients with a ring autosome. Hum Genet 75:174–179 (1987).
10.
Krauss CM, Caldwell D, Atkins L: Interstitial deletion and ring chromosome derived from 16q. J Med Genet 24:308–312 (1987).
11.
Lasan Trcic R, Hitrec V, Letica L, Cuk M, Begovic D: Small supernumerary marker chromosome derived from proximal p-arm of chromosome 2: identification by fluorescent in situ hybridization. Croat Med J 44:477–479 (2003).
12.
Liehr T, Kosyakova N, Weise A, Ziegler M, Raabe-Meyer G: First case of a neocentromere formation in an otherwise normal chromosome 7. Cytogenet Genome Res 128:189–191 (2010).
13.
Mantzouratou A, Mania A, Apergi M, Laver S, Serhal P, Delhanty J: Meiotic and mitotic behaviour of a ring/deleted chromosome 22 in human embryos determined by preimplantation genetic diagnosis for a maternal carrier. Mol Cytogenet 2:3 (2009).
14.
Marshall OJ, Chueh AC, Wong LH, Choo KH: Neocentromeres: new insights into centromere structure, disease development, and karyotype evolution. Am J Hum Genet 82:261–282 (2008).
15.
Perry J, Slater HR, Choo KH: Centric fission–simple and complex mechanisms. Chromosome Res 12:627–640 (2004).
16.
Pfeiffer RA, Trautmann U, Hirmer-Stoll R: Interstitial deletion of chromosome 9q with coexistence of the deleted segment as a ring chromosome. A case report. Ann Genet 34:247–251 (1991).
17.
Quack B, Van Roy N, Verschraegen-Spae MR, Klein F: Interstitial deletion and ring chromosome derived from 19q. Proximal 19q trisomy phenotype. Ann Genet 35:241–244 (1992).
18.
Santaguida S, Musacchio A: The life and miracles of kinetochores. EMBO J 28:2511–2531 (2009).
19.
Schinzel AA, Robinson WP, Binkert F, Fanconi A: An interstitial deletion of proximal 8q (q11–q13) in a girl with Silver-Russell syndrome-like features. Clin Dysmorphol 3:63–69 (1994).
20.
Schuffenhauer S, Kobelt A, Daumer-Haas C, Loffler C, et al: Interstitial deletion 5p accompanied by dicentric ring formation of the deleted segment resulting in trisomy 5p13-cen. Am J Med Genet 65:56–59 (1996).
21.
Ventura M, Weigl S, Carbone L, Cardone MF, Misceo D, et al: Recurrent sites for new centromere seeding. Genome Res 14:1696–1703 (2004).
22.
Warburton PE: Chromosomal dynamics of human neocentromere formation. Chromosome Res 12:617–626 (2004).
23.
Warburton PE, Dolled M, Mahmood R, Alonso A, Li S, et al: Molecular cytogenetic analysis of 8 inversion duplications of human chromosome 13q that each contain a neocentromere. Am J Hum Genet 66:1794–1806 (2000).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.